|
Wednesday October 25, 2000 COMPANY PRESS RELEASE Transgenomic, Inc. Conference Call On the Web LIVE Conference Call on the Web Notification Release Transgenomic, Inc. Invites You to Join Its Third Quarter Conference Call on the Web SAN JOSE, Calif. and OMAHA, Neb., Oct 25, 2000 /PRNewswire via COMTEX/ -- In connection with Transgenomic, Inc.'s reporting of third quarter financial results, you are invited to listen to its conference call that will be broadcast live over the Internet on Tuesday, October 31 at 5:00 p.m., EST, with Collin D'Silva, Chief Executive Officer. Transgenomic, Inc. (Nasdaq:TBIO) will release its financial results on Tuesday, October 31 at 4:00 p.m. EST.
Transgenomic provides innovative research tools to the genomics segment of the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics. We believe our WAVE System will become a leading tool to analyze genetic mutations. The WAVE System allows researchers to analyze both known and unknown genetic mutations faster, with more accuracy and at a lower cost than other commercially available techniques. Please feel free to visit the company's Website: www.transgenomic.com If you are unable to participate during the live webcast, the call will be archived for 90 days on the Web site http://www.videonewswire.com/TRANSGENOMIC/103100/. A link to this will also be located on the company's Website. (Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from www.real.com/products/player/index.html, and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an e-mail to webmaster@vdat.com.) Certain statements made within this release are forward looking and can be identified by words such as "believe", and "will become". Such statements are subject to certain factors, risks and uncertainties described from time to time in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. SOURCE: Transgenomic, Inc. (C) 2000 PR Newswire. All rights reserved. For confirmation of release or further information contact: |